Prevymis (letermovir) - Merck (MSD)
Identification of a binding pocket of letermovir in the terminase subunit pUL56 of human cytomegalovirus. (PubMed, Sci Rep) - Mar 26, 2025 - "This results in a changed distribution of the Gibbs free binding energy. To circumvent the absolute resistance of C325 mutations a further modification of letermovir might solve the problem and leads to optimizing drug targeting capacity." 
Journal • Cytomegalovirus Infection
http://www.ncbi.nlm.nih.gov/pubmed/40133489
 
Elke Bogner; Hans Tietze; Lukas M Kmetsch
 
Mar 26, 2025
 
Prev Next